MIRA INFORM REPORT

 

 

Report Date :

10.10.2013

 

IDENTIFICATION DETAILS

 

Name :

IHARA SCIENCE CORPORATION 

 

 

Registered Office :

3F, Toshin Takanawa Bldg., 3-11-3, Takanawa, Minato-Ku, 108-0074

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

21.05.1947

 

 

Legal Form :

Public Parent Company

 

 

Line of Business :

manufacturer and sale of piping joints and valves, the piping construction works, as well as the design, construction and contract works for machinery and equipment installation.

 

 

No. of Employees :

449

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Japan

A1

A1

 

Risk Category

ECGC Classification

 

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

japan ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Newly-elected Prime Minister Shinzo ABE has declared the economy his government's top priority; he has pledged to reconsider his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus and regulatory reform and has said he will press the Bank of Japan to loosen monetary policy. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2012 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.

 

Source : CIA

 

 


 

Company name & address

 

IHARA SCIENCE CORPORATION

3F

Toshin Takanawa Bldg., 3-11-3, Takanawa

Minato-Ku, 108-0074

Japan

Tel:       81-3-67216981

Fax:      81-3-67216991

Web:    www.ihara-sc.co.jp

           

 

Synthesis

 

Employees:                 449

Company Type:            Public Parent

Traded:                         Tokyo Stock Exchange: 5999

Incorporation Date:        21-May-1947

Auditor:                       Toyo Audit       

Financials in:                 USD (Millions)

Fiscal Year End:            31-Mar-2013

Reporting Currency:       Japanese Yen

Annual Sales:               110.4  1

Net Income:                 9.2

Total Assets:                145.5  2

Market Value:               90.6 (27-Sep-2013)

 

 

Business Description     

 

IHARA SCIENCE CORPORATION is mainly engaged in the manufacture and sale of piping joints and valves, the piping construction works, as well as the design, construction and contract works for machinery and equipment installation. In addition, the Company is also engaged in the design, manufacture, contract works and sale of piping systems and components. The Company's products include automatic weld fittings (AWFs), metal gasket seal type fittings, double ferule type tube fittings, bite type tube fittings, threaded fittings and socket weld fittings, ball valves, stop valves, bellows valves and metal diaphragm valves, as well as hoses and pipes. As of March 31, 2012, the Company had two consolidated subsidiaries. In November 2012, it established a China-based wholly owned subsidiary, which is engaged in the sale of the Company's products and the provision of related hardware and software services. In January 2013, the Company established a South Korea-based subsidiary. For the three months ended 30 June 2013, IHARA SCIENCE CORPORATION revenues decreased 2% to Y2.45B. Net income applicable to common stockholders decreased 4% to Y171M. Revenues reflect Gifu Office segment decrease of 10% to Y889M, IPEC Gifu Establishment Business segment decrease of 2% to Y300M, Other segment decrease of 4% to Y141M. Net income also reflects Gifu Office segment income decrease of 14% to Y402M.

 

Industry            

Industry           Metal Products Manufacturing

ANZSIC 2006:   2299 - Other Fabricated Metal Product Manufacturing Not Elsewhere Classified

ISIC Rev 4:        2813 - Manufacture of other pumps, compressors, taps and valves

NACE Rev 2:     2814 - Manufacture of other taps and valves

NAICS 2012:     332911 - Industrial Valve Manufacturing

UK SIC 2007:    2814 - Manufacture of other taps and valves

US SIC 1987:    3491 - Industrial Valves

 

           

Key Executives   

 

Name

Title

Tokuo Nakano

President, Chief Operating Officer, Representative Director

Masaji Nagao

Managing Executive Officer, Manager of Development Supervision Office, Chief Director of Sales, Director of Overseas Sales, Director

Sumihiko Iwamoto

Executive Officer, Manager of Business Supervision Office, Director

Mitsihiko Kawai

Auditor

Katsuyuki Hioki

Executive Officer, Director of CP Business, Manager of Shizuoka Business Center, Director

 

 

Significant Developments  

 

 

Topic

#*

Most Recent Headline

Date

Negative Earnings Pre-Announcement

1

IHARA SCIENCE CORP Lowers Consolidated Full-year Outlook for FY 2013

9-Nov-2012

New Business / Unit / Subsidiary

2

IHARA SCIENCE CORP to Establish New Subsidiary

21-Dec-2012

 

* number of significant developments within the last 12 months  

 

 

Financial Summary    

 

 

As of 30-Jun-2013

Key Ratios

Company

Industry

Current Ratio (MRQ)

4.59

2.87

Quick Ratio (MRQ)

3.87

1.37

Debt to Equity (MRQ)

0.21

0.76

Sales 5 Year Growth

-7.88

1.49

Net Profit Margin (TTM) %

8.25

3.92

Return on Assets (TTM) %

5.34

2.89

Return on Equity (TTM) %

8.69

4.01

 

 


Stock Snapshot  

 

 

Traded: Tokyo Stock Exchange: 5999

 

As of 27-Sep-2013

   Financials in: JPY

Recent Price

641.00

 

EPS

65.66

52 Week High

750.00

 

Price/Sales

0.98

52 Week Low

475.00

 

Price/Earnings

9.21

Avg. Volume (mil)

0.0012

 

Price/Book

0.84

Market Value (mil)

8,974.00

 

Beta

0.45

 

Price % Change

Rel S&P 500%

4 Week

-5.18%

-13.86%

13 Week

7.91%

0.49%

52 Week

12.65%

-31.02%

Year to Date

16.55%

-17.70%

 

 

 

 

1 - Profit & Loss Item Exchange Rate: USD 1 = JPY 82.97047

2 - Balance Sheet Item Exchange Rate: USD 1 = JPY 94.08855

 

 

Corporate Overview

 

Location

3F

Toshin Takanawa Bldg., 3-11-3, Takanawa

Minato-Ku, 108-0074

Japan

Tel:       81-3-67216981

Fax:      81-3-67216991

Web:    www.ihara-sc.co.jp

           

Quote Symbol - Exchange

5999 - Tokyo Stock Exchange

Sales JPY(mil):             9,158.0

Assets JPY(mil):           13,687.0

Employees:                  449

Fiscal Year End:            31-Mar-2013

Industry:                       Miscellaneous Fabricated Products

Incorporation Date:        21-May-1947

Company Type:             Public Parent

Quoted Status:              Quoted

 

 

President, Chief Operating Officer, Representative Director:    

Tokuo Nakano

 

Industry Codes

ANZSIC 2006 Codes:

2299     -          Other Fabricated Metal Product Manufacturing Not Elsewhere Classified

 

ISIC Rev 4 Codes:

2813     -          Manufacture of other pumps, compressors, taps and valves

 

NACE Rev 2 Codes:

2814     -          Manufacture of other taps and valves

 

NAICS 2012 Codes:

332911  -          Industrial Valve Manufacturing

332912  -          Fluid Power Valve and Hose Fitting Manufacturing

332919  -          Other Metal Valve and Pipe Fitting Manufacturing

 

US SIC 1987:

3491     -          Industrial Valves

3494     -          Valves and Pipe Fittings, Not Elsewhere Classified

3492     -          Fluid Power Valves and Hose Fittings

 

UK SIC 2007:

2814     -          Manufacture of other taps and valves

Business Description

IHARA SCIENCE CORPORATION is mainly engaged in the manufacture and sale of piping joints and valves, the piping construction works, as well as the design, construction and contract works for machinery and equipment installation. In addition, the Company is also engaged in the design, manufacture, contract works and sale of piping systems and components. The Company's products include automatic weld fittings (AWFs), metal gasket seal type fittings, double ferule type tube fittings, bite type tube fittings, threaded fittings and socket weld fittings, ball valves, stop valves, bellows valves and metal diaphragm valves, as well as hoses and pipes. As of March 31, 2012, the Company had two consolidated subsidiaries. In November 2012, it established a China-based wholly owned subsidiary, which is engaged in the sale of the Company's products and the provision of related hardware and software services. In January 2013, the Company established a South Korea-based subsidiary. For the three months ended 30 June 2013, IHARA SCIENCE CORPORATION revenues decreased 2% to Y2.45B. Net income applicable to common stockholders decreased 4% to Y171M. Revenues reflect Gifu Office segment decrease of 10% to Y889M, IPEC Gifu Establishment Business segment decrease of 2% to Y300M, Other segment decrease of 4% to Y141M. Net income also reflects Gifu Office segment income decrease of 14% to Y402M.

 

More Business Descriptions

·         Manufacture of high pressure valves and associated pipe work

·         Metal Valve & Pipe Fitting Mfr

·         Plastics Pipe, Pipe Fitting, and Unlaminated Profile Shape Manufacturing

 

Financial Data

Financials in:

JPY(mil)

 

Revenue:

9,158.0

Net Income:

760.0

Assets:

13,687.0

Long Term Debt:

1,291.0

 

Total Liabilities:

4,723.0

 

Working Capital:

5.3

 

 

 

Date of Financial Data:

31-Mar-2013

 

1 Year Growth

-10.6%

8.7%

-2.9%

 

Market Data

Quote Symbol:

5999

Exchange:

Tokyo Stock Exchange

Currency:

JPY

Stock Price:

641.0

Stock Price Date:

09-27-2013

52 Week Price Change %:

12.7

Market Value (mil):

8,974,000.0

 

SEDOL:

6458476

ISIN:

JP3148400009

 

Equity and Dept Distribution:

FY'98 to 02 WAS were estimated. Consolidated Financials start from FY'00. FY'04 WAS 13,970,503. FY'05&06 1Q&2Q WAS &o/s estimated. 3/05 WAS adjusted. FY'08 Q3 WAS & O/S were estimated. FY'08 2Q WAS was estimated.FY'08 1Q reported EPS&EDPS=Y31.13.FY'09 1Q reported EPS&DEPS=Y28.95.

 

Shareholders

 

 

Major Shareholders

Company's Tr.Stock (16.5%); Uni Charm (9.2%); Takahara Kosan (8.8%)

 

 

 

 

Key Corporate Relationships

Auditor:

Toyo Audit

 

Auditor:

Toyo Audit

 

 

 

 

 

 

 

 

 

 

Executive report

 

Board of Directors

 

Name

Title

Function

 

Katsuyuki Hioki

 

Executive Officer, Director of CP Business, Manager of Shizuoka Business Center, Director

Director/Board Member

 

Biography:

Mr. Katsuyuki Hioki has been serving as Executive Officer, Director of CP Business, Manager of Shizuoka Business Center and Director in IHARA SCIENCE CORPORATION since January 2013. He joined the Company in April 1981. His previous titles include Director of MF Business, Manager of Gifu Business Center, Manager of Chiba Business Center, Director of IPEC Business and Director of IT Business in the Company.

 

Age: 50

 

Sumihiko Iwamoto

 

Executive Officer, Manager of Business Supervision Office, Director

Director/Board Member

 

 

Biography:

Mr. Sumihiko Iwamoto has been serving as Executive Officer, Manager of Business Supervision Office and Director of IHARA SCIENCE CORPORATION since July 16, 2013. He joined the Company in April 1977 and used to serve as Manager of Market Development Office.

 

Age: 58

 

Masaji Nagao

 

Managing Executive Officer, Manager of Development Supervision Office, Chief Director of Sales, Director of Overseas Sales, Director

Director/Board Member

 

 

Biography:

Mr. Masaji Nagao has been serving as Managing Executive Officer, Manager of Development Supervision Office, Chief Director of Sales, Director of Overseas Sales and Director of IHARA SCIENCE CORPORATION since May 1, 2013. He joined the Company in September 2011 and used to serve as Manager of Market Development Office. He used to work for several other companies, including Hitachi, Ltd. and Hitachi Air Conditioning Products Europe, S.A.

 

Age: 64

 

Satoshi Nagaoka

 

Executive Officer, Director of GP Business, Director

Director/Board Member

 

 

Biography:

Mr. Satoshi Nagaoka has been serving as Executive Officer, Director of GP Business and Director in IHARA SCIENCE CORPORATION since May 1, 2013. He joined the Company in April 2000 and previously served as Executive Officer, Director of CP Business and Manager of Yamagata Business Center in the Company. He used to work for a subsidiary of the Company.

 

Age: 51

 

Tokuo Nakano

 

President, Chief Operating Officer, Representative Director

Director/Board Member

 

 

Biography:

Mr. Tokuo Nakano has been serving as President, Chief Operating Officer and Representative Director in IHARA SCIENCE CORPORATION since May 1999. He joined the Company in May 1969. His previous titles include Senior Managing Director, Managing Director and Director of Sales of the Company.

 

Age: 72

 

 

 

 

Executives

 

Name

Title

Function

 

Tokuo Nakano

 

President, Chief Operating Officer, Representative Director

President

 

Biography:

Mr. Tokuo Nakano has been serving as President, Chief Operating Officer and Representative Director in IHARA SCIENCE CORPORATION since May 1999. He joined the Company in May 1969. His previous titles include Senior Managing Director, Managing Director and Director of Sales of the Company.

 

Age: 72

 

Hiromichi Furukawa

 

Executive Officer, Leader of Area Development Team, Leader of GB Team

Division Head Executive

 

 

Shigeyasu Hasegawa

 

Executive Officer, Director of MF Business

Division Head Executive

 

 

Katsuyuki Hioki

 

Executive Officer, Director of CP Business, Manager of Shizuoka Business Center, Director

Division Head Executive

 

 

Biography:

Mr. Katsuyuki Hioki has been serving as Executive Officer, Director of CP Business, Manager of Shizuoka Business Center and Director in IHARA SCIENCE CORPORATION since January 2013. He joined the Company in April 1981. His previous titles include Director of MF Business, Manager of Gifu Business Center, Manager of Chiba Business Center, Director of IPEC Business and Director of IT Business in the Company.

 

Age: 50

 

Sumihiko Iwamoto

 

Executive Officer, Manager of Business Supervision Office, Director

Division Head Executive

 

 

Biography:

Mr. Sumihiko Iwamoto has been serving as Executive Officer, Manager of Business Supervision Office and Director of IHARA SCIENCE CORPORATION since July 16, 2013. He joined the Company in April 1977 and used to serve as Manager of Market Development Office.

 

Age: 58

 

Hiroshi Miyagawa

 

Executive Officer, Leader of Market Development Team

Division Head Executive

 

 

Age: 53

 

Masaji Nagao

 

Managing Executive Officer, Manager of Development Supervision Office, Chief Director of Sales, Director of Overseas Sales, Director

Division Head Executive

 

 

Biography:

Mr. Masaji Nagao has been serving as Managing Executive Officer, Manager of Development Supervision Office, Chief Director of Sales, Director of Overseas Sales and Director of IHARA SCIENCE CORPORATION since May 1, 2013. He joined the Company in September 2011 and used to serve as Manager of Market Development Office. He used to work for several other companies, including Hitachi, Ltd. and Hitachi Air Conditioning Products Europe, S.A.

 

Age: 64

 

Satoshi Nagaoka

 

Executive Officer, Director of GP Business, Director

Division Head Executive

 

 

Biography:

Mr. Satoshi Nagaoka has been serving as Executive Officer, Director of GP Business and Director in IHARA SCIENCE CORPORATION since May 1, 2013. He joined the Company in April 2000 and previously served as Executive Officer, Director of CP Business and Manager of Yamagata Business Center in the Company. He used to work for a subsidiary of the Company.

 

Age: 51

 

Hiroshi Ohyama

 

Executive Officer, Manager of Yamagata Business Center

Division Head Executive

 

 

Kazunari Tanabe

 

Executive Officer, Director of Domestic Sales

Division Head Executive

 

 

Biography:

Mr. Kazunari Tanabe has been serving as Executive Officer and Director of Domestic Sales in IHARA SCIENCE CORPORATION since February 2, 2012. He used to be Team Leader of Area Exploitation of the Company.

 

Hideho Yajima

 

Executive Officer, Manager of Yamagata Business Center

Division Head Executive

 

 

Tadao Yamamoto

 

Executive Officer, Manager of Sales Supervisor Office

Division Head Executive

 

 

Mitsihiko Kawai

 

Auditor

Accounting Executive

 

 

Mitsuya Miyasaka

 

Auditor

Accounting Executive

 

 

Takeshi Sogame

 

Auditor

Accounting Executive

 

 

 



Significant Developments

 

 

 

IHARA SCIENCE CORP to Establish New Subsidiary Dec 21, 2012


IHARA SCIENCE CORP announced that it has decided to establish a subsidiary, which will be engaged in provision of hard soft service, based in South Korea, in January 2013. The Company will hold a 60% stake in the subsidiary and e-Tech Co. Ltd will hold a 40% stake in the subsidiary. 

 

IHARA SCIENCE CORP to Establish China-based Subsidiary Nov 09, 2012


IHARA SCIENCE CORP announced that it has decided to establish a China-based wholly owned subsidiary, which will be engaged in the sale of the Company's products and the provision of related hardware and software services, in November 2012. The subsidiary will be capitalized at JPY 50 million. 

 

IHARA SCIENCE CORP Lowers Consolidated Full-year Outlook for FY 2013 Nov 09, 2012


IHARA SCIENCE CORP announced that it has lowered its consolidated full-year outlook for revenue from JPY 10,700 million to JPY 9,240 million, operating profit from JPY 1,800 million to JPY 1,100 million, ordinary profit from JPY 1,770 million to JPY 1,020 million, net profit from JPY 1,100 million to JPY 630 million and earning per share from JPY 94.17 to JPY 53.93, for the fiscal year ending March 2013. The Company lowered the outlook due to the less-than-expected sales, among others. 

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

110.4

129.8

122.8

70.5

106.2

Revenue

110.4

129.8

122.8

70.5

106.2

Total Revenue

110.4

129.8

122.8

70.5

106.2

 

 

 

 

 

 

    Cost of Revenue

77.6

90.6

82.2

52.5

75.8

Cost of Revenue, Total

77.6

90.6

82.2

52.5

75.8

Gross Profit

32.8

39.2

40.6

18.1

30.4

 

 

 

 

 

 

    Selling/General/Administrative Expense

7.3

9.1

7.7

5.4

6.9

    Labor & Related Expense

8.1

9.3

8.5

7.7

7.9

Total Selling/General/Administrative Expenses

15.4

18.4

16.2

13.1

14.8

Research & Development

2.6

2.8

2.5

2.0

1.2

    Depreciation

0.6

0.4

0.3

0.3

0.2

Depreciation/Amortization

0.6

0.4

0.3

0.3

0.2

    Litigation

0.0

0.0

-

-

-

    Impairment-Assets Held for Sale

0.0

0.0

0.0

0.1

0.1

    Other Unusual Expense (Income)

0.0

0.2

0.5

-0.1

0.3

Unusual Expense (Income)

0.0

0.3

0.5

0.1

0.4

    Other Operating Expense

0.0

-

-

-

-

Other Operating Expenses, Total

0.0

-

-

-

-

Total Operating Expense

96.1

112.5

101.7

67.9

92.5

 

 

 

 

 

 

Operating Income

14.3

17.2

21.1

2.6

13.7

 

 

 

 

 

 

        Interest Expense - Non-Operating

-0.3

-0.2

-0.2

-0.3

-0.3

    Interest Expense, Net Non-Operating

-0.3

-0.2

-0.2

-0.3

-0.3

        Interest Income - Non-Operating

0.0

0.0

0.0

0.0

0.0

        Investment Income - Non-Operating

0.6

-0.1

-0.4

-0.2

-0.3

    Interest/Investment Income - Non-Operating

0.6

-0.1

-0.4

-0.2

-0.3

Interest Income (Expense) - Net Non-Operating Total

0.4

-0.3

-0.6

-0.5

-0.5

Gain (Loss) on Sale of Assets

-0.1

-0.2

-0.2

-0.1

-0.1

    Other Non-Operating Income (Expense)

-0.1

-0.1

1.0

2.8

0.5

Other, Net

-0.1

-0.1

1.0

2.8

0.5

Income Before Tax

14.4

16.7

21.3

4.9

13.6

 

 

 

 

 

 

Total Income Tax

5.3

7.9

8.6

2.1

6.3

Income After Tax

9.2

8.9

12.7

2.8

7.3

 

 

 

 

 

 

    Minority Interest

-

-

-

-

0.0

Net Income Before Extraord Items

9.2

8.9

12.7

2.8

7.3

Net Income

9.2

8.9

12.7

2.8

7.3

 

 

 

 

 

 

    Miscellaneous Earnings Adjustment

-

-

0.0

0.0

0.0

Total Adjustments to Net Income

-

-

0.0

0.0

0.0

Income Available to Common Excl Extraord Items

9.2

8.9

12.7

2.8

7.2

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

9.2

8.9

12.7

2.8

7.2

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

11.7

11.7

11.7

11.8

12.7

Basic EPS Excl Extraord Items

0.78

0.76

1.08

0.23

0.57

Basic/Primary EPS Incl Extraord Items

0.78

0.76

1.08

0.23

0.57

Dilution Adjustment

-

-

0.0

0.0

0.0

Diluted Net Income

9.2

8.9

12.7

2.8

7.2

Diluted Weighted Average Shares

11.7

11.7

11.7

11.8

12.7

Diluted EPS Excl Extraord Items

0.78

0.76

1.08

0.23

0.57

Diluted EPS Incl Extraord Items

0.78

0.76

1.08

0.23

0.57

Dividends per Share - Common Stock Primary Issue

0.18

0.19

0.18

0.11

0.20

Gross Dividends - Common Stock

2.1

2.2

2.0

1.3

2.3

Interest Expense, Supplemental

0.3

0.2

0.2

0.3

0.3

Depreciation, Supplemental

3.7

3.6

3.3

3.7

3.6

Total Special Items

0.1

0.4

0.6

0.1

0.6

Normalized Income Before Tax

14.5

17.2

22.0

5.0

14.2

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.0

0.2

0.3

0.1

0.3

Inc Tax Ex Impact of Sp Items

5.3

8.1

8.9

2.2

6.6

Normalized Income After Tax

9.2

9.1

13.1

2.9

7.6

 

 

 

 

 

 

Normalized Inc. Avail to Com.

9.2

9.1

13.1

2.8

7.5

 

 

 

 

 

 

Basic Normalized EPS

0.79

0.78

1.11

0.24

0.60

Diluted Normalized EPS

0.79

0.78

1.11

0.24

0.60

Rental Expenses

0.5

0.8

0.7

0.6

0.6

Research & Development Exp, Supplemental

2.6

2.8

2.5

2.0

1.2

Reported Operating Profit

14.3

17.5

21.6

2.7

14.2

Reported Ordinary Profit

14.4

17.0

21.8

4.9

14.0

Normalized EBIT

14.3

17.5

21.6

2.7

14.2

Normalized EBITDA

17.9

21.2

24.9

6.4

17.8

    Current Tax - Total

5.3

5.7

-

-

-

Current Tax - Total

5.3

5.7

-

-

-

    Deferred Tax - Total

0.0

2.1

-

-

-

Deferred Tax - Total

0.0

2.1

-

-

-

Income Tax - Total

5.3

7.9

-

-

-

Service Cost - Domestic

-

-

-

-

1.0

Other Pension, Net - Domestic

1.4

-

1.6

1.3

-

Domestic Pension Plan Expense

1.4

-

1.6

1.3

1.0

Total Pension Expense

1.4

-

1.6

1.3

1.0

Total Plan Service Cost

-

-

-

-

1.0

Total Plan Other Expense

1.4

-

1.6

1.3

-

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

94.088557

82.385362

82.88

93.44

98.77

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

53.8

67.4

68.3

50.2

47.5

Cash and Short Term Investments

53.8

67.4

68.3

50.2

47.5

        Provision for Doubtful Accounts

-

-

0.0

0.0

-0.1

    Trade Accounts Receivable - Net

21.3

27.5

26.6

18.8

16.1

    Other Receivables

-

-

0.0

1.7

0.0

Total Receivables, Net

21.3

27.5

26.6

20.5

16.1

    Inventories - Finished Goods

3.7

4.3

4.0

3.0

3.5

    Inventories - Work In Progress

3.7

4.7

5.8

4.8

5.4

    Inventories - Raw Materials

7.0

8.4

8.4

6.7

7.1

Total Inventory

14.5

17.5

18.2

14.5

16.0

    Deferred Income Tax - Current Asset

1.0

0.7

1.8

1.7

1.4

    Other Current Assets

1.1

1.9

1.6

2.2

1.2

Other Current Assets, Total

2.1

2.6

3.4

3.9

2.7

Total Current Assets

91.7

114.9

116.5

89.1

82.2

 

 

 

 

 

 

Property/Plant/Equipment - Net

39.3

45.6

27.3

25.4

26.1

Intangibles, Net

1.2

1.4

0.9

0.9

1.0

    LT Investment - Affiliate Companies

0.8

-

-

0.0

-

    LT Investments - Other

5.6

1.0

0.7

0.6

0.5

Long Term Investments

6.4

1.0

0.7

0.7

0.5

Note Receivable - Long Term

0.0

0.1

0.0

0.0

0.0

    Deferred Income Tax - Long Term Asset

5.4

6.5

7.4

6.3

6.9

    Other Long Term Assets

1.3

1.7

1.5

1.1

1.1

Other Long Term Assets, Total

6.8

8.2

8.9

7.4

8.0

Total Assets

145.5

171.1

154.3

123.4

117.8

 

 

 

 

 

 

Accounts Payable

3.6

5.3

6.1

4.2

1.6

Accrued Expenses

0.0

0.2

0.2

0.0

-

Notes Payable/Short Term Debt

4.2

5.0

0.4

0.3

0.3

Current Portion - Long Term Debt/Capital Leases

3.2

4.9

6.3

7.0

6.1

    Income Taxes Payable

2.5

1.1

8.5

0.0

1.3

    Other Payables

2.0

2.6

3.8

2.7

2.3

    Other Current Liabilities

1.0

0.5

1.3

0.4

0.8

Other Current liabilities, Total

5.5

4.3

13.5

3.1

4.4

Total Current Liabilities

16.5

19.6

26.6

14.5

12.4

 

 

 

 

 

 

    Long Term Debt

13.7

26.0

9.9

14.5

15.9

Total Long Term Debt

13.7

26.0

9.9

14.5

15.9

Total Debt

21.2

35.9

16.7

21.8

22.3

 

 

 

 

 

 

    Reserves

0.6

0.6

0.6

0.0

-

    Pension Benefits - Underfunded

17.6

20.9

20.7

18.5

18.0

    Other Long Term Liabilities

1.8

2.1

1.5

1.3

1.3

Other Liabilities, Total

20.0

23.6

22.9

19.9

19.3

Total Liabilities

50.2

69.2

59.4

48.9

47.5

 

 

 

 

 

 

    Common Stock

16.6

19.0

18.9

16.7

15.8

Common Stock

16.6

19.0

18.9

16.7

15.8

Additional Paid-In Capital

6.6

7.5

7.5

6.6

6.3

Retained Earnings (Accumulated Deficit)

90.5

96.6

89.7

69.1

65.2

Treasury Stock - Common

-18.5

-21.1

-21.0

-18.0

-17.0

Unrealized Gain (Loss)

0.1

0.0

0.0

0.1

0.0

    Translation Adjustment

0.0

-

0.0

0.0

0.0

    Other Equity

0.0

-

-

-

-

Other Equity, Total

0.1

-

0.0

0.0

0.0

Total Equity

95.3

101.9

95.0

74.6

70.2

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

145.5

171.1

154.4

123.4

117.8

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

11.7

11.7

11.7

11.8

11.8

Total Common Shares Outstanding

11.7

11.7

11.7

11.8

11.8

Treasury Shares - Common Stock Primary Issue

2.3

2.3

2.3

2.2

2.2

Employees

449

451

456

449

444

Number of Common Shareholders

785

705

728

759

778

Total Long Term Debt, Supplemental

22.0

42.0

23.7

21.6

22.1

Long Term Debt Maturing within 1 Year

6.9

12.3

8.9

7.1

6.2

Long Term Debt Maturing in Year 2

4.2

7.9

4.9

5.7

5.7

Long Term Debt Maturing in Year 3

3.7

4.9

3.7

4.4

4.4

Long Term Debt Maturing in Year 4

3.7

4.3

0.7

3.3

3.1

Long Term Debt Maturing in Year 5

0.3

4.3

0.1

0.6

2.1

Long Term Debt Maturing in 2-3 Years

7.9

12.8

8.7

10.1

10.1

Long Term Debt Maturing in 4-5 Years

4.0

8.6

0.8

3.9

5.2

Long Term Debt Matur. in Year 6 & Beyond

3.1

8.3

5.3

0.5

0.6

Pension Obligation - Domestic

16.7

19.4

19.2

17.1

16.6

Plan Assets - Domestic

1.1

0.8

0.3

0.3

0.4

Funded Status - Domestic

-15.6

-18.6

-18.8

-16.8

-16.2

Total Funded Status

-15.6

-18.6

-18.8

-16.8

-16.2

Accrued Liabilities - Domestic

-15.6

-

-18.8

-16.8

-16.2

Net Assets Recognized on Balance Sheet

-15.6

-

-18.8

-16.8

-16.2

Total Plan Obligations

16.7

19.4

19.2

17.1

16.6

Total Plan Assets

1.1

0.8

0.3

0.3

0.4

 

 

Annual Cash Flows

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

14.4

16.7

21.3

4.9

13.5

    Depreciation

3.7

3.6

3.3

3.7

3.6

Depreciation/Depletion

3.7

3.6

3.3

3.7

3.6

    Unusual Items

0.0

0.0

0.5

0.1

0.1

    Other Non-Cash Items

-0.6

0.0

0.0

-0.2

-1.1

Non-Cash Items

-0.6

0.1

0.5

-0.1

-1.0

    Accounts Receivable

3.1

-0.7

-5.2

-1.8

11.9

    Inventories

0.4

0.9

-1.8

2.4

1.9

    Accounts Payable

-1.5

-2.2

2.1

3.0

-5.9

    Accrued Expenses

-0.2

-0.1

0.2

0.0

0.0

    Other Operating Cash Flow

-2.8

-14.1

2.8

-5.7

-8.6

Changes in Working Capital

-0.9

-16.1

-2.0

-2.2

-0.7

Cash from Operating Activities

16.5

4.3

23.2

6.3

15.4

 

 

 

 

 

 

    Purchase of Fixed Assets

-3.0

-22.0

-1.7

-2.0

-2.1

    Purchase/Acquisition of Intangibles

-0.2

-0.6

0.0

0.0

-0.1

Capital Expenditures

-3.1

-22.6

-1.7

-2.0

-2.2

    Sale of Fixed Assets

-

-

0.0

0.0

0.0

    Sale/Maturity of Investment

-

-

0.0

0.0

0.0

    Purchase of Investments

-5.9

-0.3

0.0

0.0

0.0

    Other Investing Cash Flow

0.2

-0.7

-0.4

0.0

0.0

Other Investing Cash Flow Items, Total

-5.8

-1.0

-0.4

-0.1

-0.1

Cash from Investing Activities

-8.9

-23.6

-2.1

-2.0

-2.3

 

 

 

 

 

 

    Other Financing Cash Flow

-

0.0

-

-

-

Financing Cash Flow Items

-

0.0

-

-

-

    Cash Dividends Paid - Common

-2.1

-2.2

-1.4

-2.5

-2.6

Total Cash Dividends Paid

-2.1

-2.2

-1.4

-2.5

-2.6

        Repurchase/Retirement of Common

0.0

0.0

-0.7

0.0

-8.4

    Common Stock, Net

0.0

0.0

-0.7

0.0

-8.4

Issuance (Retirement) of Stock, Net

0.0

0.0

-0.7

0.0

-8.4

    Short Term Debt, Net

0.0

0.3

0.0

0.0

0.0

        Long Term Debt Issued

0.0

29.2

0.0

5.3

9.8

        Long Term Debt Reduction

-11.6

-9.6

-7.7

-7.1

-10.6

    Long Term Debt, Net

-11.6

19.6

-7.7

-1.8

-0.8

Issuance (Retirement) of Debt, Net

-11.6

19.9

-7.6

-1.8

-0.8

Cash from Financing Activities

-13.7

17.7

-9.7

-4.3

-11.9

 

 

 

 

 

 

Foreign Exchange Effects

0.1

0.2

0.0

0.0

0.1

Net Change in Cash

-5.9

-1.3

11.3

-0.1

1.3

 

 

 

 

 

 

Net Cash - Beginning Balance

66.9

71.7

54.7

50.5

45.4

Net Cash - Ending Balance

61.0

70.3

66.1

50.4

46.7

Cash Interest Paid

0.3

0.2

0.3

0.3

0.3

Cash Taxes Paid

3.4

13.5

-1.1

4.4

8.5

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Total net sales

110.4

129.8

122.8

70.5

106.2

Total Revenue

110.4

129.8

122.8

70.5

106.2

 

 

 

 

 

 

    Rounding adjustment Income Statement

0.0

-

-

-

-

    Total cost of sales

77.6

90.6

82.2

52.5

75.8

    Other Selling/General/Admin. Expense

3.7

4.9

-

-

-

    Freight Cost

2.2

2.4

2.1

1.1

1.7

    Director Compensation

1.6

2.0

1.8

1.7

1.8

    Payroll

4.2

4.5

4.0

3.8

3.9

    Bonus

1.0

1.2

1.1

0.9

1.0

    Legal Benefits

0.8

0.8

0.8

0.6

0.7

    Periodic Retirement Benefits

0.3

0.4

0.4

0.4

0.2

    Pro'n for directots' retirement benefit

0.3

0.3

0.3

0.3

0.4

    Allowance for Director Bonu

0.0

0.2

0.2

-

-

    Rental Expenses

0.5

0.8

0.7

0.6

0.6

    Travel

1.0

1.0

0.9

0.8

0.8

    Depreciation

0.6

0.4

0.3

0.3

0.2

    Research & Development

2.6

2.8

2.5

2.0

1.2

    Other General Expenses

-

-

4.0

2.9

3.8

    Other

-

0.0

-

-

-

    SP Head office transfer cost

0.0

0.2

-

-

-

    SP Rev. of allowance for doubtful accou

-

-

0.0

-0.1

0.0

    SP L-Valu. Inv. Secs.

-

-

0.0

0.1

0.0

    SP Litigation Settlement(1)

0.0

0.0

-

-

-

    SP Receipts for land contract cancel.

-

-

-

-

0.0

    SP L on retire. of inventories

-

-

-

0.0

0.0

    SP L on Prior Adjustment

-

-

-

0.0

0.3

    SP Loss Valuation Membership

0.0

0.0

0.0

0.0

0.1

    SP L on adjustment for changes of accoun

-

0.0

0.5

0.0

-

    SP Other Special Loss

-

-

0.0

0.0

0.0

Total Operating Expense

96.1

112.5

101.7

67.9

92.5

 

 

 

 

 

 

    Equity In Losses Of Affiliates

-0.1

-

-

-

-

    Foreign Exchange Gains

0.7

-

-

-

-

    SP Loss-Dispos. Fixed

-

-

-

0.0

0.0

    NOP Interest &Divid. Inc

0.0

0.0

0.0

0.0

0.0

    Other Non-Operating Income (Expense)

0.0

0.0

-

-

-

    NOP Commission for insurance office work

0.0

0.0

-

-

-

    NOP Purchase Discount

-

0.0

0.0

0.0

0.1

    NOP Contract revenue

-

-

-

0.0

0.2

    NOP Insuran. prem. refunded cancellation

-

0.0

0.9

0.0

-

    NOP Subsidy

-

0.0

0.1

2.9

0.4

    Miscellaneous income

0.1

0.1

0.2

0.3

0.1

    NOP Interest Expense

-0.3

-0.2

-0.2

-0.3

-0.3

    NOP Loss-Sale Bills

-0.1

-0.2

-0.2

-0.1

-0.1

    NOP Exchange Loss

0.0

-0.1

-0.4

-0.2

-0.3

    NOP Sale Discount

-

-

0.0

0.0

-0.1

    NOP Bond Issue Cost

-

-

0.0

-0.1

-0.2

    NOP Equity Method loss

-

-

-

0.0

0.0

    Miscellaneous loss

-0.2

-0.1

-0.2

-0.3

-0.1

Net Income Before Taxes

14.4

16.7

21.3

4.9

13.6

 

 

 

 

 

 

Total income taxes

5.3

7.9

8.6

2.1

6.3

Net Income After Taxes

9.2

8.9

12.7

2.8

7.3

 

 

 

 

 

 

    Minority Interest

-

-

-

-

0.0

Net Income Before Extra. Items

9.2

8.9

12.7

2.8

7.3

Net Income

9.2

8.9

12.7

2.8

7.3

 

 

 

 

 

 

    Adjustment

-

-

0.0

0.0

0.0

Income Available to Com Excl ExtraOrd

9.2

8.9

12.7

2.8

7.2

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

9.2

8.9

12.7

2.8

7.2

 

 

 

 

 

 

Basic Weighted Average Shares

11.7

11.7

11.7

11.8

12.7

Basic EPS Excluding ExtraOrdinary Items

0.78

0.76

1.08

0.23

0.57

Basic EPS Including ExtraOrdinary Items

0.78

0.76

1.08

0.23

0.57

Dilution Adjustment

-

-

0.0

0.0

0.0

Diluted Net Income

9.2

8.9

12.7

2.8

7.2

Diluted Weighted Average Shares

11.7

11.7

11.7

11.8

12.7

Diluted EPS Excluding ExtraOrd Items

0.78

0.76

1.08

0.23

0.57

Diluted EPS Including ExtraOrd Items

0.78

0.76

1.08

0.23

0.57

DPS-Ordinary Shares

0.18

0.19

0.18

0.11

0.20

Gross Dividends - Common Stock

2.1

2.2

2.0

1.3

2.3

Normalized Income Before Taxes

14.5

17.2

22.0

5.0

14.2

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

5.3

8.1

8.9

2.2

6.6

Normalized Income After Taxes

9.2

9.1

13.1

2.9

7.6

 

 

 

 

 

 

Normalized Inc. Avail to Com.

9.2

9.1

13.1

2.8

7.5

 

 

 

 

 

 

Basic Normalized EPS

0.79

0.78

1.11

0.24

0.60

Diluted Normalized EPS

0.79

0.78

1.11

0.24

0.60

Interest Expense

0.3

0.2

0.2

0.3

0.3

Rental Expense

0.5

0.8

0.7

0.6

0.6

R&D Expenses

2.6

2.8

2.5

2.0

1.2

BC - Depreciation of Fixed Assets

3.7

-

-

-

-

Amort of Tangible Assets-Current Portion

-

3.6

-

-

-

Depreciation

-

-

3.3

3.7

3.6

    Income taxes-current

5.3

5.7

-

-

-

Current Tax - Total

5.3

5.7

-

-

-

    Income taxes-deferred

0.0

2.1

-

-

-

Deferred Tax - Total

0.0

2.1

-

-

-

Income Tax - Total

5.3

7.9

-

-

-

Reported Operating Profit

14.3

17.5

21.6

2.7

14.2

Reported Ordinary Profit

14.4

17.0

21.8

4.9

14.0

Service Cost

-

-

-

-

1.0

Retirement Benefit Expenses Retirement B

1.4

-

-

-

-

Pension Plan Expense

-

-

1.6

1.3

-

Domestic Pension Plan Expense

1.4

-

1.6

1.3

1.0

Total Pension Expense

1.4

-

1.6

1.3

1.0

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

94.088557

82.385362

82.88

93.44

98.77

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Deposit

53.8

67.4

68.3

50.2

47.5

    Notes and accounts receivable-trade

21.3

27.5

26.6

18.8

16.1

    Inventories - merchandise&finished goods

3.7

4.3

4.0

3.0

3.5

    Inventories - work-in-process

3.7

4.7

5.8

4.8

5.4

    Inventories - raw materials&supplies

7.0

8.4

8.4

6.7

7.1

    Deferred Tax

1.0

0.7

1.8

1.7

1.4

    Income tax receivable

-

-

0.0

1.7

0.0

    Rounding adjustment Assets

0.0

0.0

-

-

-

    Other Assets

1.0

1.8

1.6

2.2

1.2

    Allowance for doubtful accounts

-

-

0.0

0.0

-0.1

Total Current Assets

91.7

114.9

116.5

89.1

82.2

 

 

 

 

 

 

    Other total PPE

0.0

-

-

-

-

    other PPE,net

-

0.0

-

-

-

    Buildings and structures, net

16.9

20.4

12.8

11.9

11.1

    Machinery, equipment and vehicles, net

5.4

6.3

6.9

7.4

8.8

    Land

15.1

17.2

6.3

5.6

5.1

    Const. Progress

1.4

0.8

0.9

0.2

0.5

    Other, net

0.5

0.8

0.4

0.3

0.5

    Total intangible assets

1.2

1.4

0.9

0.9

1.0

    Investment Securities - Balancing value

5.6

-

-

-

-

    Investment Secs.

-

1.0

0.7

0.6

0.5

    Invt Secs Noncons, Asc, Affd Cos

0.8

-

-

-

-

    Investment Secs.

-

-

-

0.0

-

    Long-term loans receivable

0.0

0.1

0.0

0.0

0.0

    Rounding adjustment Assets

0.0

-

-

-

-

    Other Total investments and other assets

0.0

-

-

-

-

    Other Other Long Term Assets

-

0.0

-

-

-

    Insur.Rsrv.Fund

0.8

0.8

0.7

0.2

0.2

    Deferred tax assets

5.4

6.5

7.4

6.3

6.9

    Other Assets

0.5

0.8

0.8

0.8

0.9

    Allowance for doubtful accounts

0.0

0.0

0.0

0.0

0.0

    Adjustment

-

-

-

0.1

0.1

Total Assets

145.5

171.1

154.3

123.4

117.8

 

 

 

 

 

 

    Accounts payable-trade

3.6

5.3

6.1

4.2

1.6

    Current -P Bond

3.2

4.9

6.3

7.0

6.1

    Short-term loans payable

4.2

5.0

0.4

0.3

0.3

    Accounts payable-other

2.0

2.6

3.8

2.7

2.3

    Tax Payable

2.5

1.1

8.5

0.0

1.3

    Provision for directors'' bonuses

0.0

0.2

0.2

0.0

-

    Rounding adjustment Liability

0.0

0.0

-

-

-

    Other Liability

1.0

0.5

1.3

0.4

0.8

Total Current Liabilities

16.5

19.6

26.6

14.5

12.4

 

 

 

 

 

 

    Corporate Bond

0.5

4.2

9.0

13.6

14.9

    Long-term loans payable

13.2

21.8

0.9

0.9

0.9

Total Long Term Debt

13.7

26.0

9.9

14.5

15.9

 

 

 

 

 

 

    Allow.Acc.Retire

15.6

18.6

18.8

16.8

16.2

    Asset retirement obligations

0.6

0.6

0.6

0.0

-

    Provision for directors'' retirement ben

1.9

2.2

1.9

1.8

1.8

    Rounding adjustment Liability

0.0

-

-

-

-

    Other Long Term Liabilities

-

0.0

-

-

-

    Rounding adjustment Liability

-

0.0

-

-

-

    Other Liability

1.8

2.1

1.5

1.3

1.3

Total Liabilities

50.2

69.2

59.4

48.9

47.5

 

 

 

 

 

 

    Rounding adjustment Equity

0.0

-

-

-

-

    Common Stock

16.6

19.0

18.9

16.7

15.8

    Total capital surpluses

6.6

7.5

7.5

6.6

6.3

    Total retained earnings

90.5

96.6

89.7

69.1

65.2

    Valuation difference on available-for-sa

0.1

0.0

0.0

0.1

0.0

    Foreign Currency Translation Adjustment

0.0

-

-

-

-

    Foreign currency translation adjustment

-

-

0.0

0.0

0.0

    Treasury Stock

-18.5

-21.1

-21.0

-18.0

-17.0

Total Equity

95.3

101.9

95.0

74.6

70.2

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

145.5

171.1

154.4

123.4

117.8

 

 

 

 

 

 

    S/O-Ordinary Shares

11.7

11.7

11.7

11.8

11.8

Total Common Shares Outstanding

11.7

11.7

11.7

11.8

11.8

T/S-Ordinary Shares

2.3

2.3

2.3

2.2

2.2

Full-Time Employees

449

451

456

449

444

Total Number of Shareholders

785

705

-

-

-

Number of Common Shareholders

-

-

728

759

778

Within One Year

3.2

4.9

-

-

-

Division And End Of Current Period Remai

3.7

5.9

-

-

-

Division And End Of Current Period Remai

-

1.5

-

-

-

Long Term Debt Maturing within 1 Yr

-

-

8.9

7.1

6.2

Over One Year And Within Two Years

0.5

3.6

-

-

-

Lns Pble Maturing over a Yr within 2 Yrs

3.7

4.3

-

-

-

Long Term Debt Maturing within 2 Yr

-

-

4.9

5.7

5.7

Over Two Years And Within Three Years

-

0.6

-

-

-

Lns Pble Maturg over 2 Yrs within 3 Yrs

3.7

4.3

-

-

-

Long Term Debt Maturing within 3 Yr

-

-

3.7

4.4

4.4

Over Three Years And Within Four Years

-

0.0

-

-

-

Over Four Years And Within Five Years

-

0.0

-

-

-

Lns Pble Maturg over 3 Yrs within 4 Yrs

3.7

4.3

-

-

-

Long Term Debt Maturing within 4 Yr

-

-

0.7

3.3

3.1

Lns Pble Maturg over 4 Yrs within 5 Yrs

0.3

4.3

-

-

-

Long Term Debt Maturing within 5 Yr

-

-

0.1

0.6

2.1

Other Interest Bearing-guarantee deposit

1.3

-

-

-

-

remaining LT debt payable

1.8

8.3

-

-

-

Long Term Debt Remaining Maturity

-

-

5.3

0.5

0.6

Total Long Term Debt, Supplemental

22.0

42.0

23.7

21.6

22.1

Pension Obligation

16.7

19.4

19.2

17.1

16.6

Fair Value of Plan Assets

1.1

0.8

0.3

0.3

0.4

Funded Status - Total/No Break-down

-15.6

-18.6

-

-

-

Funded Status

-

-

-18.8

-16.8

-16.2

Total Funded Status

-15.6

-18.6

-18.8

-16.8

-16.2

Accrued Pension Benefits

-15.6

-

-18.8

-16.8

-16.2

Net Assets Recognized on Balance Sheet

-15.6

-

-18.8

-16.8

-16.2

 

 

 

Annual Cash Flows

Financials in: USD (mil)

 

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Mar-2013

Updated Normal 
31-Mar-2012

Updated Normal 
31-Mar-2011

Updated Normal 
31-Mar-2010

Updated Normal 
31-Mar-2009

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

82.970472

78.961215

85.691434

92.941082

100.484331

Auditor

Toyo Audit

Toyo Audit

Toyo Audit

Toyo Audit

Deloitte & Touche LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Net Income Bf. Tax

14.4

16.7

21.3

4.9

13.5

    Depreciation

3.7

3.6

3.3

3.7

3.6

    Increase (decrease) in provision for ret

-0.7

-0.3

-0.1

-0.4

-1.6

    Increase (decrease) in provision for dir

0.0

0.3

-0.1

-0.1

0.2

    Increase (decrease) in provision for dir

-0.2

-0.1

0.2

0.0

0.0

    Increase (decrease) in allowance for dou

0.0

0.0

0.0

-0.1

0.0

    Interest &Dividend

0.0

0.0

0.0

0.0

0.0

    Interest Expense

0.3

0.2

0.2

0.3

0.3

    Bond Issue Cost

-

-

0.0

0.1

0.2

    Foreign exchange losses (gains)

-0.1

-0.2

0.0

0.0

-0.1

    Rounding adjustment Cash flow

0.0

-

-

-

-

    Other Operating Cash Flow

-

0.0

-

-

-

    Loss on adjustment for changes of accoun

-

-

0.5

0.0

-

    Loss (gain) on valuation of investment s

0.0

-

0.0

0.1

0.0

    L-Dispos. Fixed

-

-

-

0.0

0.0

    Receipts for land contract cancel.

-

-

-

-

0.0

    Loss on valuation of golf club membershi

0.0

0.0

0.0

0.0

0.1

    Decrease (increase) in notes and account

3.1

-0.7

-5.2

-1.8

11.9

    Decrease (increase) in inventories

0.4

0.9

-1.8

2.4

1.9

    Increase (decrease) in notes and account

-1.2

-0.9

1.4

2.5

-3.9

    Increase (decrease) in accounts payable-

-0.3

-1.3

0.7

0.5

-1.9

    Other, net

0.9

-0.4

1.9

-1.1

0.1

    Int.&Divid.Received

0.0

0.0

0.0

0.0

0.0

    Interest Paid

-0.3

-0.2

-0.3

-0.3

-0.3

    Tax Paid

-3.4

-13.5

1.1

-4.4

-8.5

Cash from Operating Activities

16.5

4.3

23.2

6.3

15.4

 

 

 

 

 

 

    Purchase of investments in capital of su

-0.6

-

-

-

-

    Purchase of investments in subsidiaries

0.0

-

-

-

-

    Sale Mktbl.Secs.

-

-

-

0.0

0.0

    Purchase of property, plant and equipmen

-3.0

-22.0

-1.7

-2.0

-2.1

    Sale Fixed Assets

-

-

0.0

0.0

0.0

    Purchase of intangible assets

-0.2

-0.6

0.0

0.0

-0.1

    Purch. Inv. Secs.

-5.3

-0.3

0.0

0.0

0.0

    Sale Inv. Secs.

-

-

0.0

-

-

    Rounding adjustment Cash flow

0.0

0.0

-

-

-

    Insur Rsrv. Made

-0.1

-0.1

-0.5

0.0

0.0

    Cancel Insur.Rsrv.

-

-

0.0

0.0

0.1

    Other, net

0.3

-0.5

0.0

0.0

-0.1

Cash from Investing Activities

-8.9

-23.6

-2.1

-2.0

-2.3

 

 

 

 

 

 

    Proceeds from long-term loans payable

0.0

29.2

-

-

-

    Issue Bond

-

-

0.0

5.3

9.8

    Net increase (decrease) in short-term lo

0.0

0.3

0.0

0.0

0.0

    Redemption Bond

-4.8

-6.6

-7.6

-7.0

-10.4

    Repayment of long-term loans payable

-6.8

-2.9

-0.1

-0.1

-0.1

    Dividends paid

-2.1

-2.2

-1.4

-2.5

-2.6

    Purchase of treasury stock

0.0

0.0

-0.7

0.0

-8.4

    Rounding adjustment Cash flow

-

0.0

-

-

-

Cash from Financing Activities

-13.7

17.7

-9.7

-4.3

-11.9

 

 

 

 

 

 

Foreign Exchange Effects

0.1

0.2

0.0

0.0

0.1

Net Change in Cash

-5.9

-1.3

11.3

-0.1

1.3

 

 

 

 

 

 

Net Cash - Beginning Balance

66.9

71.7

54.7

50.5

45.4

Net Cash - Ending Balance

61.0

70.3

66.1

50.4

46.7

    Cash Interest Paid

0.3

0.2

0.3

0.3

0.3

    Cash Taxes Paid

3.4

13.5

-1.1

4.4

8.5

 

 

Financial Health

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

Key Indicators USD (mil)

 

Quarter
Ending
30-Jun-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Mar-2013

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 

24.9

-1.64%

110.4

-10.64%

11.79%

-7.88%

Research & Development1 

-

-

2.6

-5.33%

4.62%

11.25%

Operating Income1 

3.0

-0.99%

14.3

-13.14%

69.02%

-14.85%

Income Available to Common Excl Extraord Items1 

1.7

-3.93%

9.2

8.73%

43.72%

-12.19%

Basic EPS Excl Extraord Items1 

0.15

-3.93%

0.78

8.73%

44.15%

-9.85%

Capital Expenditures2 

-

-

3.1

-85.43%

12.42%

-10.07%

Cash from Operating Activities2 

-

-

16.5

300.00%

32.79%

-4.87%

Free Cash Flow 

-

-

11.8

-

40.26%

-3.36%

Total Assets3 

142.5

-1.07%

145.5

-2.90%

5.87%

0.91%

Total Liabilities3 

51.3

-12.96%

50.2

-17.17%

1.11%

-3.85%

Total Long Term Debt3 

12.3

-41.33%

13.7

-39.76%

-1.67%

1.81%

Employees3 

-

-

449

-0.44%

0.00%

0.59%

Total Common Shares Outstanding3 

11.7

0.00%

11.7

0.00%

-0.29%

-2.59%

1-ExchangeRate: JPY to USD Average for Period

98.564314

 

82.970472

 

 

 

2-ExchangeRate: JPY to USD Average for Period

 

 

82.970472

 

 

 

3-ExchangeRate: JPY to USD Period End Date

98.239969

 

94.088557

 

 

 

Key Ratios

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Profitability

Gross Margin 

29.72%

30.21%

33.06%

25.63%

28.60%

Operating Margin 

12.92%

13.29%

17.21%

3.74%

12.90%

Pretax Margin 

13.06%

12.90%

17.36%

6.96%

12.77%

Net Profit Margin 

8.30%

6.82%

10.33%

3.90%

6.81%

Financial Strength

Current Ratio 

5.56

5.87

4.39

6.15

6.62

Long Term Debt/Equity 

0.14

0.26

0.10

0.19

0.23

Total Debt/Equity 

0.22

0.35

0.18

0.29

0.32

Management Effectiveness

Return on Assets 

5.47%

5.20%

8.96%

2.24%

5.92%

Return on Equity 

8.76%

8.59%

14.65%

3.68%

10.19%

Efficiency

Receivables Turnover 

4.29

4.58

5.10

3.74

4.89

Inventory Turnover 

4.60

4.85

4.92

3.33

4.56

Asset Turnover 

0.66

0.76

0.87

0.57

0.86

Market Valuation USD (mil)

P/E (TTM) 

9.94

.

Enterprise Value2 

58.9

Price/Sales (TTM) 

0.98

.

Enterprise Value/Revenue (TTM) 

0.63

Price/Book (MRQ) 

0.83

.

Enterprise Value/EBITDA (TTM) 

3.88

Market Cap as of 27-Sep-20131 

90.6

.

 

 

1-ExchangeRate: JPY to USD on 27-Sep-2013

99.027066

 

 

 

2-ExchangeRate: JPY to USD on 30-Jun-2013

98.239969

 

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)         

 

 

31-Mar-2013

31-Mar-2012

31-Mar-2011

31-Mar-2010

31-Mar-2009

Financial Strength

Current Ratio 

5.56

5.87

4.39

6.15

6.62

Quick/Acid Test Ratio 

4.56

4.84

3.57

4.88

5.12

Working Capital1 

75.2

95.4

89.9

74.6

69.8

Long Term Debt/Equity 

0.14

0.26

0.10

0.19

0.23

Total Debt/Equity 

0.22

0.35

0.18

0.29

0.32

Long Term Debt/Total Capital 

0.12

0.19

0.09

0.15

0.17

Total Debt/Total Capital 

0.18

0.26

0.15

0.23

0.24

Payout Ratio 

23.05%

25.07%

16.19%

46.04%

34.82%

Effective Tax Rate 

36.45%

47.13%

40.37%

43.20%

46.37%

Total Capital1 

116.4

137.8

111.6

96.3

92.5

 

 

 

 

 

 

Efficiency

Asset Turnover 

0.66

0.76

0.87

0.57

0.86

Inventory Turnover 

4.60

4.85

4.92

3.33

4.56

Days In Inventory 

79.34

75.24

74.14

109.63

80.10

Receivables Turnover 

4.29

4.58

5.10

3.74

4.89

Days Receivables Outstanding 

85.03

79.61

71.53

97.57

74.62

Revenue/Employee2 

216,779

275,839

278,542

156,264

243,376

Operating Income/Employee2 

28,003

36,656

47,945

5,840

31,400

EBITDA/Employee2 

35,199

44,408

55,460

14,015

39,746

 

 

 

 

 

 

Profitability

Gross Margin 

29.72%

30.21%

33.06%

25.63%

28.60%

Operating Margin 

12.92%

13.29%

17.21%

3.74%

12.90%

EBITDA Margin 

16.24%

16.10%

19.91%

8.97%

16.33%

EBIT Margin 

12.92%

13.29%

17.21%

3.74%

12.90%

Pretax Margin 

13.06%

12.90%

17.36%

6.96%

12.77%

Net Profit Margin 

8.30%

6.82%

10.33%

3.90%

6.81%

R&D Expense/Revenue 

2.33%

2.20%

2.04%

2.84%

1.14%

COGS/Revenue 

70.28%

69.79%

66.94%

74.37%

71.40%

SG&A Expense/Revenue 

13.97%

14.21%

13.19%

18.56%

13.94%

 

 

 

 

 

 

Management Effectiveness

Return on Assets 

5.47%

5.20%

8.96%

2.24%

5.92%

Return on Equity 

8.76%

8.59%

14.65%

3.68%

10.19%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 

1.01

-1.50

1.90

0.37

1.14

Operating Cash Flow/Share 2 

1.25

0.36

2.05

0.53

1.33

1-ExchangeRate: JPY to USD Period End Date

94.088557

82.385362

82.88

93.44

98.77

2-ExchangeRate: JPY to USD Average for Period

94.088557

82.385362

82.88

93.44

98.77

 

Current Market Multiples

Market Cap/Earnings (TTM) 

11.92

Market Cap/Equity (MRQ) 

1.00

Market Cap/Revenue (TTM) 

0.98

Market Cap/EBIT (TTM) 

7.53

Market Cap/EBITDA (TTM) 

6.01

Enterprise Value/Earnings (TTM) 

7.69

Enterprise Value/Equity (MRQ) 

0.65

Enterprise Value/Revenue (TTM) 

0.63

Enterprise Value/EBIT (TTM) 

4.86

Enterprise Value/EBITDA (TTM) 

3.88

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.92

UK Pound

1

Rs.99.45

Euro

1

Rs.83.92

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.